Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin.
Heme toxicity contributes to the pathogenesis of chronic inflammatory diseases, atherosclerosis, and hemolysis associated vasculopathy. Macrophage clearance of cell free hemoglobin (Hb) is thus an essential homeostatic function of these cells. We examined the transcriptional response of human PBMC derived macrophages to Hb by gene array analysis. The observed noninflammatory macrophage response was characterized by induction of an antioxidative and antiinflammatory gene expression pattern with most prominent induction of the inducible heme oxygenase (HO-1). The metabolically active Hb-CD163-HO-1 pathway resulted in synthesis of ferritin-1 of the antioxidative and antiinflammatory end products linked to heme breakdown by HO-1. This response was mediated by the Hb scavenger receptor CD163 and heme and was not related to Hb mediated depletion of reduced glutathione. In contrast to other cellular responses induced by CD163, there was no role of protein phosphorylation dependent CD163 signaling in the protective macrophage response to Hb. Instead, CD163 acted as an Hb transporter, which undergoes constitutive and ligand independent internalization and recycling between the cell surface and early endosomes. The expression of CD163 and HO-1 in macrophages of neovascularized atherosclerotic lesions suggests that the pathway described herein is active in vivo. Noninflammatory Hb clearance and intimately linked HO-1 expression may provide the long sought-after explanation for the antiinflammatory activity associated with CD163-positive macrophages.
Schaer
Christian A
CA
Department of Medicine, University Hospital, Zurich, Switzerland.
Schoedon
Gabriele
G
Imhof
Alexander
A
Kurrer
Michael O
MO
Schaer
Dominik J
DJ
D015703:Antigens, CD / Q000032:analysis / Q000378:metabolism* / Q000502:physiology; D015214:Antigens, Differentiation, Myelomonocytic / Q000032:analysis / Q000378:metabolism* / Q000502:physiology; D050197:Atherosclerosis / Q000378:metabolism / Q000473:pathology; D002478:Cells, Cultured; D019610:Cytoprotection; D004705:Endocytosis; D011992:Endosomes / Q000378:metabolism; D020869:Gene Expression Profiling; D015971:Gene Expression Regulation, Enzymologic; D005978:Glutathione / Q000378:metabolism; D006418:Heme / Q000378:metabolism* / Q000502:physiology; D051547:Heme Oxygenase-1 / Q000096:biosynthesis* / Q000235:genetics; D006454:Hemoglobins / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D008264:Macrophages / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D009389:Neovascularization, Pathologic / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000032:analysis / Q000378:metabolism* / Q000502:physiology; D051116:Receptors, Scavenger / Q000378:metabolism; D014158:Transcription, Genetic; D000098902:CD163 Antigen
D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D000098902:CD163 Antigen; D006454:Hemoglobins; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; D051116:Receptors, Scavenger; D006418:Heme; C496541:HMOX1 protein, human; D051547:Heme Oxygenase-1; D005978:Glutathione